推进诊断和治疗以达到儿童时期的全方位治愈 ALL
Rob Pieters1, Charles G Mullighan2, Stephen P Hunger3
1Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
概括
在最小残留性疾病 (MRD) 检测和精准医学方面的进展显著改善了儿童急性淋巴细胞白血病 (ALL) 的生存率. 新的免疫疗法提供了更少的毒性,更有效的治疗方法,旨在治愈所有患有ALL的儿童.
科学领域:
- 儿科瘤学 儿科瘤学
- 血液学 血液学 血液学
- 分子生物学分子生物学
背景情况:
- 由于几十年的化疗进展,儿童急性淋巴细胞白血病 (ALL) 存活率已上升至90%.
- 最小 (可测量的) 残留疾病 (MRD) 监测细化风险分层和治疗强度.
- 最近的分子分析已经确定了新的ALL亚型和驱动突变,增强了对生物学的理解.
研究的目的:
- 为了回顾最近的儿童诊断和治疗方面的进展,在过去的10到15年里.
- 讨论分子和免疫治疗策略的整合,以提高治愈率.
- 突出需要在全球范围内获得新,有效的ALL治疗方法.
主要方法:
- 系统化疗和内化疗疗效率的审查.
- 对最小残留疾病 (MRD) 技术进行风险分层的分析.
- 对ALL亚型和精密医学进行分子遗传分析的评估.
- 免疫疗法的评估,包括双特异性抗体,抗体-药物联合体和细胞疗法.
主要成果:
- 化疗显著增加了儿童ALL生存率.
- 敏感的MRD技术和分子分析使得个性化治疗方法成为可能.
- 免疫疗法正在替代强化化疗法和干细胞移植治疗复发性/耐药ALL,在新诊断的患者中取得了有希望的结果.
结论:
- 综合的分子和免疫治疗见解对于治愈剩余的ALL儿童至关重要.
- 未来的努力应集中在改善幸存者的生活质量上.
- 确保全球获得先进的,虽然昂贵的ALL疗法至关重要.
更多相关视频
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
29.4K
06:51Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
Published on: December 17, 2019
15.1K
相关概念视频
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:22Bone Marrow Sampling and Transplants
342
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
342
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K